Literature DB >> 3111669

The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study.

T Hansson, B Roos.   

Abstract

Daily treatment with 30 mg of sodium fluoride (NaF) and 1 g of calcium over a 3-year period increased the bone mineral content (BMC) in the spines of women (n = 25) with osteoporosis. Determination of the BMC was followed with dual photon absorptiometry (137Cs-241Am) in the third lumbar vertebra. No increase in BMC was found with only 10 mg sodium fluoride in combination with calcium (n = 25), with calcium alone (n = 25), or with placebo (n = 25). No serious side effects were registered. There was, however, minor gastrointestinal distress in one-fifth of the patients taking 30 mg NaF daily.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3111669     DOI： 10.1007/bf02556692

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


  10 in total

1.  Dual photon absorptiometry in lumbar vertebrae. II. Precision and reproducibility.

Authors:  B O Roos
Journal:  Acta Radiol Ther Phys Biol       Date:  1975-06

2.  Proceedings: Effect of combined therapy with sodium fluoride, calcium, and vitamin D on the lumbar spine in osteoporosis.

Authors:  T Hansson; B Roos
Journal:  AJR Am J Roentgenol       Date:  1976-06       Impact factor: 3.959

3.  Dual photon absorptiometry in lumbar vertebrae. I. Theory and method.

Authors:  B O Roos; H Sköldborn
Journal:  Acta Radiol Ther Phys Biol       Date:  1974-06

4.  Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis.

Authors:  J Jowsey; B L Riggs; P J Kelly; D L Hoffmann
Journal:  Am J Med       Date:  1972-07       Impact factor: 4.965

5.  [Results of long-term treatment of primary osteoporosis with sodium fluoride (author's transl)].

Authors:  H P Kruse; F Kuhlencordt; J D Ringe
Journal:  Dtsch Med Wochenschr       Date:  1978-02-10       Impact factor: 0.628

6.  The effects of fluoride therapy on metabolic bone disease. A histologic study.

Authors:  D J Baylink; D S Bernstein
Journal:  Clin Orthop Relat Res       Date:  1967 Nov-Dec       Impact factor: 4.176

7.  Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

Authors:  C Christiansen; M S Christensen; P McNair; C Hagen; K E Stocklund; I Transbøl
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

8.  Dual photon absorptiometry in lumbar vertebrae. Evaluation of the baseline error.

Authors:  B O Roos; T H Hansson; H Sköldborn
Journal:  Acta Radiol Oncol       Date:  1980

9.  Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence.

Authors:  B L Riggs; S F Hodgson; D L Hoffman; P J Kelly; K A Johnson; D Taves
Journal:  JAMA       Date:  1980-02-01       Impact factor: 56.272

10.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

Authors:  B L Riggs; E Seeman; S F Hodgson; D R Taves; W M O'Fallon
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245
  10 in total
  21 in total

Review 1.  The effect of vitamin D and calcium supplementation on falls in older adults : A systematic review and meta-analysis.

Authors:  Haiting Wu; Qingjiang Pang
Journal:  Orthopade       Date:  2017-09       Impact factor: 1.087

2.  The remodeling transient and the calcium economy.

Authors:  J F Aloia; S Arunabh-Talwar; S Pollack; J K Yeh
Journal:  Osteoporos Int       Date:  2008-01-26       Impact factor: 4.507

3.  Designing clinical trials of treatment for osteoporosis: recruitment and follow-up.

Authors:  B C Tilley; E L Peterson; M Kleerekoper; E Phillips; D A Nelson; M A Shorck
Journal:  Calcif Tissue Int       Date:  1990-12       Impact factor: 4.333

4.  What is the future for fluoride in the treatment of osteoporosis?

Authors:  J D Ringe; P J Meunier
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

5.  The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued.

Authors:  J R Talbot; M M Fischer; S M Farley; C Libanati; J Farley; A Tabuenca; D J Baylink
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 6.  Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis.

Authors:  Jia-Guo Zhao; Xian-Tie Zeng; Jia Wang; Lin Liu
Journal:  JAMA       Date:  2017-12-26       Impact factor: 56.272

7.  Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects.

Authors:  M W Lundy; M Stauffer; J E Wergedal; D J Baylink; J D Featherstone; S F Hodgson; B L Riggs
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

8.  Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study.

Authors:  J L Sebert; P Richard; I Mennecier; J P Bisset; G Loeb
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

9.  Fluoride treatment of osteoporosis: cyclical non-blinded or continuous blinded studies?

Authors:  D H Gutteridge; G N Kent; R L Prince; G C Nicholson; G O Stewart; C E Jones; C I Bhagat; B G Stuckey; R W Retallack
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 10.  Fluoride therapy of type I osteoporosis.

Authors:  J P Devogelaer; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.